This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (46)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Nutritional and Metabolic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Victor M. Montori, MD, MSc; Bruce R. Bistrian, MD, PhD; M. Molly McMahon, MD

JAMA. 2002;288:2167-2169.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Most physicians will encounter acutely ill patients who develop hyperglycemia. A third of all persons admitted to an urban general hospital had fasting glucose levels exceeding 126 mg/dL (7 mmol/L), or 2 or more random glucose levels exceeding 200 mg/dL (11.1 mmol/L); a third of those patients with hyperglycemia did not have a prior diagnosis of diabetes.¹ Physicians often perceive hyperglycemia as a consequence of stress that runs parallel to the clinical course of an acute illness. Clinicians often start treatment of hyperglycemia only after glucose levels have exceeded 200 to 250 mg/dL (11-14 mmol/L). One reason for this is the perception that avoidance of hypoglycemia and its potential consequences is more important than glycemic control while patients are hospitalized. We discuss the evidence supporting the hyperglycemic milieu as a risk factor for adverse . . . [Full Text of this Article]

Pathophysiology of Hyperglycemia

Causes of Hyperglycemia

Effects of Hyperglycemia

Benefits of Controlling Hyperglycemia

Avoidance of Hypoglycemia

Author Affiliations: Division of Endocrinology, Metabolism, Nutrition and Internal Medicine, Mayo Clinic Rochester, and Mayo Medical School, Rochester, Minn (Drs Montori and McMahon); Division of Clinical Nutrition, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass (Dr Bistrian).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Hyperglycemia in Acute Illness
Ketan Dhatariya
JAMA. 2003;289(10):1244.
EXTRACT | FULL TEXT  

Dangers to Elderly Pedestrians at Crosswalks
George J. Hill
JAMA. 2003;289(10):1244.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Moghissi et al.
Diabetes Care 2009;32:1119-1131.
FULL TEXT  

Comparison of Inpatient Insulin Regimens with Detemir plus Aspart Versus Neutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes
Umpierrez et al.
J. Clin. Endocrinol. Metab. 2009;94:564-569.
ABSTRACT | FULL TEXT  

Response
Hirshberg
Chest 2009;135:248-248.
FULL TEXT  

Management of Inpatient Hyperglycemia in Noncritically Ill Patients
Lansang and Umpierrez
Diabetes Spectr. 2008;21:248-255.
ABSTRACT | FULL TEXT  

Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials
Gandhi et al.
Mayo Clin Proc. 2008;83:418-430.
ABSTRACT | FULL TEXT  

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)
Umpierrez et al.
Diabetes Care 2007;30:2181-2186.
ABSTRACT | FULL TEXT  

Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery: A Randomized Trial
Gandhi et al.
ANN INTERN MED 2007;146:233-243.
ABSTRACT | FULL TEXT  

Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU Population
Freire et al.
Chest 2005;128:3109-3116.
ABSTRACT | FULL TEXT  

Preventing Infectious Complications With Nutrition Intervention
Martindale and Cresci
JPEN J Parenter Enteral Nutr 2005;29:S53-S56.
FULL TEXT  

Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic Crises
Stentz et al.
Diabetes 2004;53:2079-2086.
ABSTRACT | FULL TEXT  

Hospital Management of Hyperglycemia
Campbell and Braithwaite
Clin. Diabetes 2004;22:81-88.
FULL TEXT  

Absence of Inducible Nitric Oxide Synthase Reduces Myocardial Damage During Ischemia Reperfusion in Streptozotocin-Induced Hyperglycemic Mice
Marfella et al.
Diabetes 2004;53:454-462.
ABSTRACT | FULL TEXT  

Protein and energy provision in critical illness
Hoffer
Am. J. Clin. Nutr. 2003;78:906-911.
ABSTRACT | FULL TEXT  

Glucose Control and Mortality in Critically Ill Patients
Finney et al.
JAMA 2003;290:2041-2047.
ABSTRACT | FULL TEXT  

Glycemic Control in Medical Inpatients with Type 2 Diabetes Mellitus Receiving Sliding Scale Insulin Regimens versus Routine Diabetes Medications: A Multicenter Randomized Controlled Trial
Dickerson et al.
Ann Fam Med 2003;1:29-35.
ABSTRACT | FULL TEXT  

Hyperglycemia in Acute Illness
Dhatariya
JAMA 2003;289:1244-1244.
FULL TEXT  

Authors' Response: Hyperglycemia--An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
Umpierrez and Kitabchi
J. Clin. Endocrinol. Metab. 2003;88:1402-1402.
FULL TEXT